Innate Pharma SA (NASDAQ: IPHA)

$1.39 +0.00 (+0.00%)
As of Apr 06, 2026 04:00 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001598599
Market Cap 153.82 Mn
P/E -2.10
P/S 0.29
Div. Yield 0.00
Total Debt (Qtr) 26.28 Mn
Add ratio to table...

About

Attribution of expenses by nature to their function [axis] Breakdown of Revenue (2024)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 110.31 Bn 28.07 9.19 -
2 ARGX Argenx Se 46.35 Bn 35.41 1.29 -
3 ALNY Alnylam Pharmaceuticals, Inc. 43.76 Bn 157.40 13.89 -
4 ZLAB Zai Lab Ltd 22.73 Bn -128.38 93.73 0.20 Bn
5 ROIV Roivant Sciences Ltd. 19.68 Bn -31.52 3,429.14 -
6 RPRX Royalty Pharma plc 19.50 Bn 26.48 8.20 8.95 Bn
7 MRNA Moderna, Inc. 19.22 Bn -6.71 9.89 0.59 Bn
8 MESO Mesoblast Ltd 19.03 Bn -175.06 1,299.34 0.12 Bn